Eidos Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch EIDX and buy or sell other stocks, options, and ETFs commission-free!

About EIDX

BridgeBio is a clinical-stage biotech company developing novel, genetically targeted therapies to improve the lives of patients. The BridgeBio approach combines a traditional focus on drug development with a unique corporate model, allowing rapid translation of early stage science into medicines that treat disease at its source. 

CEO
Neil Kumar, PhD
CEONeil Kumar, PhD
Employees
Employees
Headquarters
San Francisco, California
HeadquartersSan Francisco, California
Founded
2013
Founded2013
Employees
Employees

EIDX Key Statistics

Market cap
4.75B
Market cap4.75B
Price-Earnings ratio
-46.10
Price-Earnings ratio-46.10
Dividend yield
Dividend yield
Average volume
138.46K
Average volume138.46K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$132.54
52 Week high$132.54
52 Week low
$28.39
52 Week low$28.39
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.